NDC 68071-3408-01 - Enalapril Maleate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-3408
- Requested NDC
- 68071-3408-01
- Package NDCs from labels
- 68071-3408-1, 68071-3408-01
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2025-01-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ENALAPRIL MALEATE TABLETS Rx only | NuCare Pharmaceuticals,Inc. | 2025-01-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3408-1 | Enalapril Maleate | 100 in 1 BOTTLE | TABLET | 100 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-3408 | ENALAPRIL MALEATE TABLET [NUCARE PHARMACEUTICALS,INC.] | 2 | Current NDC, 1 package rows | 20250104_fe2dfa84-0276-6603-e053-6394a90af8ee.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZEGERID | OMEPRAZOLE AND SODIUM BICARBONATE | Santarus, Inc.. | cd6868b9-5824-442b-8d65-4db29ecb70a4 | 2023-07-19 | Warnings, Adverse reactions | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Dr. Reddy's Laboratories Inc., | c6b5f808-4a49-1303-9711-badb022ecd70 | 2023-07-19 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | A-S Medication Solutions | 619cb558-84e5-43ea-91e9-28c764f9f9c0 | 2023-06-21 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 7a2d8dab-750f-43c1-933c-4169a840c60c | 2023-06-20 | Warnings, Adverse reactions | 8MDF5V39QO |
| Enalapril Maleate | ENALAPRIL MALEATE | A-S Medication Solutions | 7b80abb4-fa75-48a4-a2e9-b0e31205234c | 2023-05-23 | Boxed warning, Warnings, Adverse reactions | 858813 9O25354EPJ |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | b620938d-ab2d-0934-e053-2a95a90a8483 | 2023-05-23 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | d1636b56-ad83-4439-e053-2a95a90a135e | 2023-05-02 | Warnings, Adverse reactions | 8MDF5V39QO |
| Enalapril maleate | ENALAPRIL MALEATE | A-S Medication Solutions | ccdd0f67-e9d5-41e3-93d5-94b9792a6f8f | 2023-04-27 | Warnings, Adverse reactions | 858810 9O25354EPJ |
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Omeprazole, Sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Guardian Drug Company | e5c6c2cf-fb3b-456a-a0a0-be396d6f8319 | 2022-11-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Enalapril maleate oral solution | ENALAPRIL MALEATE | Camber Pharmaceuticals, Inc. | b63bdaa6-b57b-417b-9a79-29f1fd5bbf08 | 2022-02-10 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Sodium Bicarbonate | SODIUM BICARBONATE | International Medication Systems, Limited | 77698221-a01d-4568-a7bc-d3d4e982875d | 2021-12-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| 8.4% SODIUM BICARBONATE | 8.4% SODIUM BICARBONATE | HF Acquisition Co. LLC, DBA HealthFirst | 74d8bb7a-9e7a-105f-e053-2a91aa0aec92 | 2021-05-03 | Warnings, Adverse reactions | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | bfc9c321-665c-ca97-e053-2995a90a7954 | 2021-04-12 | Warnings, Adverse reactions | 8MDF5V39QO |
| Enalapril Maleate | ENALAPRIL MALEATE | OCEANSIDE PHARMACEUTICALS | ebd2a62d-a704-4f8a-a104-749a5296502f | 2020-12-01 | Boxed warning, Warnings, Adverse reactions | 858804 858810 858817 858813 9O25354EPJ |
| Vaseretic | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | Bausch Health US, LLC | bf3007e2-8fcc-48de-8fd5-55e95033d62f | 2020-08-31 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Enalapril Maleate | ENALAPRIL MALEATE | Proficient Rx LP | ca1d0143-bbd3-4041-9981-eadbb8893a2b | 2020-03-01 | Boxed warning, Warnings, Adverse reactions | 858810 9O25354EPJ |
| Enalapril Maleate | ENALAPRIL MALEATE | Proficient Rx LP | cc921315-8da1-487c-ba19-433470f5c8d8 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 858817 9O25354EPJ |
| Enalapril Maleate | ENALAPRIL | Amneal Pharmaceuticals NY LLC | e81a8aca-0e7c-4a02-b596-09e4ac22c70e | 2019-03-29 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Aphena Pharma Solutions - Tennessee, LLC | 15605a6d-6c90-47d5-9d1f-f66a3f27d5fc | 2017-12-13 | Warnings | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.